
Sign up to save your podcasts
Or
Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phase II TULIP Lupus Nephritis trial. This in-depth conversation centers on results from a clinical trial where they evaluated the efficacy of intensified anifrolumab treatment in individuals with active lupus nephritis.
Read the article: http://dx.doi.org/10.1136/lupus-2023-000910
3.9
1414 ratings
Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phase II TULIP Lupus Nephritis trial. This in-depth conversation centers on results from a clinical trial where they evaluated the efficacy of intensified anifrolumab treatment in individuals with active lupus nephritis.
Read the article: http://dx.doi.org/10.1136/lupus-2023-000910
11,158 Listeners
41 Listeners
5 Listeners
49 Listeners
7 Listeners
5 Listeners
3 Listeners
3 Listeners
3 Listeners
10 Listeners
39 Listeners
14 Listeners
1 Listeners
47 Listeners
1 Listeners
6 Listeners
498 Listeners
281 Listeners
3,332 Listeners
3 Listeners
90 Listeners
24 Listeners
1,105 Listeners
1,672 Listeners
23 Listeners
350 Listeners
23 Listeners
32 Listeners
368 Listeners
43 Listeners
2 Listeners
0 Listeners
0 Listeners
2 Listeners